MPO and cancer: Multiple studies link the G463A polymorphism in the MPO promoter region, which decreases the transcription and activity of MPO, with a lower cancer risk for a variety of human cancers e.g. pancreatic cancer22, bladder cancer23 and gastric cancer24.